In Su Seo

Dr. In Su Seo

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
DKDong-Yeon Kim
Dong-Yeon Kim
TLTae-Sung Lee
Tae-Sung Lee
DJDo-Hyeon Jung
Do-Hyeon Jung
ESEun-Jung Song
Eun-Jung Song
AJAh-Ra Jang
Ah-Ra Jang
Jong-Hwan ParkJong-Hwan Park
Jong-Hwan Park
Inflammatory bowel disease (IBD) is an intestinal chronic inflammatory disease, and its incidence is steadily increasing. IBD is closely related to the intestinal microbiota, and probiotics are known to be a potential therapeutic agent for IBD. In our study, we evaluated the protective effect of Lactobacillus sakei CVL-001, isolated from Baechu kimchi, on dextran sulfated sodium (DSS)-induced colitis in mice. The oral administration of L. sakei CVL-001 according to the experimental schedule alleviated weight loss and disease activity in the mice with colitis. Furthermore, the length and histopathology of the colon improved. The expression of tumor necrosis factor (TNF)-α and interleukin (IL)-1β genes decreased in the colons of mice that were administered L. sakei CVL-001, whereas that of IL-10 increased. The expressions of genes coding for E-cadherin, claudin3, occludin, and mucin were also restored. In co-housed conditions, L. sakei CVL-001 administration did not improve disease activity, colon length, and histopathology. Microbiota analysis revealed that L. sakei CVL-001 administration increased the abundance of microbiota and altered Firmicutes/Bacteroidetes ratio, and decreased Proteobacteria. In conclusion, L. sakei CVL-001 administration protects mice from DSS-induced colitis by regulating immune response and intestinal integrity via gut microbiota modulation.


23 January 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
AJAh-Ra Jang
Ah-Ra Jang
YKYeong-Jun Kim
Yeong-Jun Kim
ISIn Su Seo
In Su Seo
WKWan-Gyu Kim
Wan-Gyu Kim
SJSang-Eun Jung
Sang-Eun Jung
Jong-Hwan ParkJong-Hwan Park
Jong-Hwan Park
Helicobacter pylori is a prevalent gastric pathogen that establishes chronic infection and contributes to gastritis, peptic ulcer disease, and gastric cancer. Its persistence depends on immune evasion strategies that promote sustained low-grade inflammation in the gastric mucosa. Nucleotide-binding oligomerization domain-like receptors (NLRs) are cytosolic pattern recognition receptors that play key roles in innate immune responses against H. pylori. Nod1 and Nod2 detect bacterial peptidoglycan delivered via the type IV secretion system or outer membrane vesicles, activating NF-κB, MAPK, and interferon signaling pathways that regulate inflammatory cytokine production, epithelial barrier function, autophagy, and antimicrobial defense. The NLRP3 inflammasome mediates the maturation of IL-1β and IL-18 primarily in myeloid cells, thereby shaping inflammatory and immunoregulatory responses during infection. In contrast, NLRC4 functions in a context-dependent manner in epithelial cells and is largely dispensable for myeloid IL-1β production. Emerging evidence also implicates noncanonical NLRs, including NLRP6, NLRP9, NLRP12, NLRX1, and NLRC5, in regulating inflammation, epithelial homeostasis, and gastric tumorigenesis. In addition, genetic polymorphisms in NLR genes influence host susceptibility to H. pylori-associated diseases. This review highlights the interplay between NLR signaling, bacterial virulence, and host immunity and identifies potential therapeutic targets.

22 July 2025 in Phytomedicine
Verified
Journal Article
Closed access
DJDo-Hyeon Jung
Do-Hyeon Jung
SJSang-Eun Jung
Sang-Eun Jung
TLTae-Sung Lee
Tae-Sung Lee
YKYeong-Jun Kim
Yeong-Jun Kim
YLYun-Ji Lee
Yun-Ji Lee
Jong-Hwan ParkJong-Hwan Park
Jong-Hwan Park

30 November 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
AJAh-Ra Jang
Ah-Ra Jang
YLYun-Ji Lee
Yun-Ji Lee
DKDong-Yeon Kim
Dong-Yeon Kim
TLTae-Sung Lee
Tae-Sung Lee
DJDo-Hyeon Jung
Do-Hyeon Jung
Jong-Hwan ParkJong-Hwan Park
Jong-Hwan Park
Osteoporosis, which is often associated with increased osteoclast activity due to menopause or aging, was the main focus of this study. We investigated the inhibitory effects of water extract of desalted Salicornia europaea L. (WSE) on osteoclast differentiation and bone loss in ovariectomized mice. Our findings revealed that WSE effectively inhibited RANKL-induced osteoclast differentiation, as demonstrated by TRAP staining, and also suppressed bone resorption and F-actin ring formation in a dose-dependent manner. The expression levels of genes related to osteoclast differentiation, including NFATc1, ACP5, Ctsk, and DCSTAMP, were downregulated by WSE. Oral administration of WSE improved bone density and structural parameters in ovariectomized mice. Dicaffeoylquinic acids (DCQAs) and saponins were detected in WSE, with 3,4-DCQA, 3,5-DCQA, and 4,5-DCQA being isolated and identified. All tested DCQAs, including the aforementioned types, inhibited osteoclast differentiation, bone resorption, and the expression of osteoclast-related genes. Furthermore, WSE and DCQAs reduced ROS production mediated by RANKL. These results indicate the potential of WSE and its components, DCQAs, as preventive or therapeutic agents against osteoporosis and related conditions.

6 November 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
AJAh-Ra Jang
Ah-Ra Jang
YLYun-Ji Lee
Yun-Ji Lee
DKDong-Yeon Kim
Dong-Yeon Kim
TLTae-Sung Lee
Tae-Sung Lee
DJDo-Hyeon Jung
Do-Hyeon Jung
Jong-Hwan ParkJong-Hwan Park
Jong-Hwan Park
Osteoporosis, often linked to increased osteoclast activity due to menopause or aging, was the focus. In this study, the inhibitory effects of Salicornia europaea L. (SE) water extract of desalted SE (WSE) were investigated on osteoclast differentiation and bone loss in ovariectomized mice. The findings revealed that WSE effectively inhibited RANKL-induced osteoclast differentiation, as evidenced by TRAP staining, and also suppressed bone resorption and F-actin ring formation in a dose-dependent manner. Gene expressions related to osteoclast differentiation, including NFATc1, TRAP, cathepsin K, and DC-STAMP, were downregulated by WSE. Oral administration of WSE improved bone density and structural parameters in ovariectomized mice. Dicaffeoyl quinic acids (DCQAs) and saponins in WSE were detected, with 3,4-, 3,5-, and 4,5-DCQA isolated and identified. All tested DCQAs, including the aforementioned types, inhibited osteoclast differentiation, bone resorption, and the expression of osteoclast-related genes. Furthermore, WSE and DCQAs reduced ROS production mediated by RANKL. These results indicate the potential of WSE and its components, DCQA, as preventive or therapeutic agents against osteoporosis and related conditions.